Megaloblastic Anemia

Definition

Pathophysiology

1. Folate cycle: Tetrahydrofolate (THF) is the ultimate one-carbon donor required to convert dUMP → dTMP (via thymidylate synthase). Adequate THF depends on vitamin B12.
2. B12's role - the "methylfolate trap": Methyl-THF (the main plasma form of folate) can only be converted back to THF via methionine synthase, which requires vitamin B12 (methylcobalamin). When B12 is absent, methyl-THF accumulates and cannot be recycled into usable THF - this is the methylfolate trap. The result is secondary folate deficiency even when folate stores are adequate.
3. Second B12 reaction: Adenosylcobalamin is required for L-methylmalonyl-CoA mutase, which converts methylmalonyl-CoA → succinyl-CoA. When blocked, methylmalonic acid (MMA) accumulates - this is the basis of the most specific lab test for B12 deficiency.
4. Net effect: Defective dTMP synthesis → uracil incorporation into DNA → chromosomal damage, prolonged cell cycle, maturation arrest, and apoptosis of hematopoietic precursors (ineffective hematopoiesis). - Robbins Pathology & Goldman-Cecil Medicine

Causes

Vitamin B12 (Cobalamin) Deficiency

Folate Deficiency

Other Causes (Not Responsive to B12/Folate)

• Chemotherapy agents: hydroxyurea, azathioprine, cytarabine
• Antiretrovirals: zidovudine, stavudine
• Tyrosine kinase inhibitors: imatinib
• Inborn errors: hereditary orotic aciduria, Lesch-Nyhan syndrome, thiamine-responsive megaloblastic anemia (SLC19A2 mutation)

Morphology

Peripheral Blood Smear

• Macro-ovalocytes - large oval red cells, MCV often >115 fL, appear "hyperchromic" (but MCHC is not elevated)
• Hypersegmented neutrophils - 5+ nuclear lobes (normal: 3-4 lobes); >5% neutrophils with ≥5 lobes, or any neutrophil with ≥6 lobes is pathological
• Anisocytosis and poikilocytosis (teardrop cells)
• Low reticulocyte count (ineffective erythropoiesis)
• Pancytopenia in severe cases

Hypersegmented neutrophil (6-lobed nucleus) - classic finding. Robbins Pathology, Fig. 14.15

Bone Marrow

Bone marrow aspirate: megaloblasts in various stages. Note cytoplasmic hemoglobinization (B) with retained, non-pyknotic nucleus - nuclear-cytoplasmic asynchrony. - Robbins Pathology, Fig. 14.16

• Hypercellular marrow (response to elevated erythropoietin)
• Megaloblasts - large erythroid precursors with finely distributed ("open") chromatin, cytoplasm matures normally while nucleus lags
• Nuclear-cytoplasmic asynchrony - the hallmark: cytoplasm is hemoglobinized but nucleus remains immature (non-pyknotic)
• Giant metamyelocytes and band forms (granulocytic dysmaturation)
• Hypersegmented megakaryocytes

Pernicious Anemia (the Classic B12 Deficiency Syndrome)

• Anti-intrinsic factor (blocking) antibodies - 50-70% sensitive, highly specific
• Anti-parietal cell antibodies - 90% sensitive, less specific (also positive in other autoimmune gastritis)

• Subacute combined degeneration of the cord - demyelination of dorsal and lateral columns
  • Symptoms: peripheral neuropathy, loss of vibration and position sense, ataxia, upper motor neuron signs, psychiatric disturbances ("megaloblastic madness")
  • Key point: neurological complications can occur with minimal or no anemia, and folate supplementation does NOT improve (and may worsen) the neuropathy
• Glossitis - smooth, beefy-red tongue
• Jaundice - mild, from intramedullary hemolysis (elevated LDH, indirect bilirubin)
• Increased risk of gastric carcinoma and gastric carcinoids - gastric mucosa atrophy and metaplasia persist even with B12 treatment

Laboratory Diagnosis

B12 Deficiency vs. Folate Deficiency: Key Differences

Treatment

Vitamin B12 Deficiency

• Parenteral B12 (cyanocobalamin or hydroxocobalamin): IM injections, typically 1000 µg daily × 7 days, then weekly × 4, then monthly for life (in pernicious anemia)
• High-dose oral B12: 1000-2000 µg/day - effective even in pernicious anemia because passive diffusion (IF-independent) absorbs ~1% of large oral doses. This is now widely used as an alternative to injections.
• Response: Reticulocyte crisis begins within 3-5 days; hematocrit improves over weeks; neurological improvement occurs if treated early (may be irreversible if delayed)
• Gastric mucosal changes in pernicious anemia are NOT reversed by treatment

Folate Deficiency

• Folic acid: 1-5 mg/day orally
• Must never give folate alone when B12 deficiency is suspected or untreated - this corrects the anemia and masks the diagnosis while neurological damage continues
• Supplementation in pregnancy (400 µg/day) prevents neural tube defects

Acute Megaloblastic Anemia

• Can be precipitated by nitrous oxide anesthesia in subclinically B12-deficient patients
• Treat underlying cause; consider cofactor replacement

Key Clinical Pearls

1. Severity of anemia is inversely related to severity of neuropathy in B12 deficiency - patients with severe neurological disease may have mild or no anemia.
2. Folate supplementation cannot substitute for B12 in pernicious anemia - the neurological lesion (related to methylmalonyl-CoA pathway) is folate-independent.
3. Pancytopenia - megaloblastic anemia can affect all cell lines; do not assume isolated marrow disease.
4. Alcoholism - macrocytosis in alcoholics may be masked by coexisting iron deficiency; think of combined deficiencies.
5. Drugs - metformin, PPIs, and anticonvulsants are common iatrogenic causes to remember.
6. Pernicious anemia patients need at least one screening endoscopy for gastric adenocarcinoma and carcinoid tumors.